CDT CONDUIT PHARMACEUTICALS INC.

Nasdaq www.conduitpharma.com


$ 3.89 $ -0.27 (-6.65 %)    

Tuesday, 14-Oct-2025 17:40:09 EDT
QQQ $ 599.28 $ -4.01 (-0.67 %)
DIA $ 463.09 $ 2.03 (0.44 %)
SPY $ 663.23 $ -0.81 (-0.12 %)
TLT $ 90.60 $ 0.29 (0.32 %)
GLD $ 381.05 $ 2.70 (0.71 %)
$ 3.79
$ 3.79
$ 3.80 x 5
$ 3.90 x 1,500
$ 3.56 - $ 4.18
$ 3.40 - $ 2,198.40
124,543
na
1.45M
$ -0.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-20-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-17-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cdt-equity-announces-1-for-8-reverse-stock-split-effective-october-10-2025

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-f...

 cdt-equity-announces-strategic-purchase-of-865-bitcoin-for-1m-at-an-average-price-of-115285-per-btc

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the strategic acquisition of 8.65252366 B...

 cdt-equity-identifies-new-biological-target-and-therapeutic-use-for-azd1656-through-ai-driven-drug-repurposing

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announces that it has successfully identified a new...

 conduit-pharma-intends-to-change-its-name-to-cdt-equity-inc

Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential...

 conduit-pharmaceuticals-files-new-four-patents-related-to-assets-azd1656-and-azd5658

Includes Conduit's first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION